Seattle-based Adaptive Biotechnologies and Microsoft have launched an open-access database called ImmuneCODE to catalog the many ways in which our immune systems fight off a coronavirus infection. The project leverages… Read More
Billionaire philanthropist Paul Allen died two months ago, but before he passed away, he passed along a $125 million commitment to a new research frontier: the Allen Institute for Immunology.… Read More
Immunotherapies are quickly increasing survival rates for some of the deadliest cancers in the world. A new study on immunotherapy Keytruda found that using the treatment, in combination with chemotherapy,… Read More
NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More